GEN and GNMSF Related Headlines

Go Back

GEN and GNMSF Related Press Releases

Go Back

Apr 17, 2014 03:52PM GSK and Genmab Receive FDA Approval for Arzerra(r) (ofatumumab) as First-Line Treatment in Combination with Chlorambucil for Patients with Chronic Lymphocytic Leukemia (CLL) for Whom Fludarabine-Based
Apr 9, 2014 11:11AM Passing of Genmab A/S' Annual General Meeting
Mar 26, 2014 06:57PM Genmab Reaches $22 Million Milestone in Daratumumab Collaboration with Janssen
Mar 5, 2014 12:47AM Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma
Mar 4, 2014 11:23AM Genmab 2013 Annual Report
Feb 5, 2014 07:15AM Arzerra(R) Fourth Quarter and Full Year 2013 Net Sales Figures
Jan 29, 2014 01:57PM Major Shareholder Announcement

GEN and GNMSF Related SEC Filings

Go Back